Long term effects of the treatment of polycythemia vera (PV) with recombinant interferon alfa (rIFNα).

被引：0
|
作者：
Silver, RT
Pahuja, M
Klein, J
机构：
[1] New York Presbyterian Hosp, Div Hematol Oncol, New York, NY USA
[2] Weill Cornell Med Ctr, New York, NY USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3205
引用
收藏
页码：741A / 741A
页数：1
相关论文
共 50 条
  • [31] TREATMENT OF HEMANGIOMATOSIS WITH RECOMBINANT INTERFERON ALFA
    WHITE, CW
    SEMINARS IN HEMATOLOGY, 1990, 27 (03) : 15 - 22
  • [32] Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b
    Kiladjian, Jean-Jacques
    Klade, Christoph
    Georgiev, Pencho
    Krochmalczyk, Dorota
    Gercheva-Kyuchukova, Liana
    Egyed, Miklos
    Dulicek, Petr
    Illes, Arpad
    Pylypenko, Halyna
    Sivcheva, Lylia
    Mayer, Jiri
    Yablokova, Vera
    Krejcy, Kurt
    Empson, Victoria
    Hasselbalch, Hans C.
    Kralovics, Robert
    Gisslinger, Heinz
    LEUKEMIA, 2022, 36 (05) : 1408 - 1411
  • [33] Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
    Silver, Richard T.
    Kiladjian, Jean-Jacques
    Hasselbalch, Hans Carl
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (01) : 49 - 58
  • [34] RECOMBINANT INTERFERON ALFA 2A (RIFN-ALFA-A) IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    HIRSCH, FW
    KRAATZ, B
    BROSS, KJ
    LOHR, GW
    BLUT, 1987, 55 (04): : 363 - 363
  • [35] LONG-TERM TREATMENT WITH INTERFERON-ALPHA-2B FOR SEVERE PRURITUS IN PATIENTS WITH POLYCYTHEMIA-VERA
    MULLER, EW
    DEWOLF, JTM
    EGGER, R
    WIJERMANS, PW
    HUIJGENS, PC
    HALIE, MR
    VELLENGA, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (02) : 313 - 318
  • [36] Long-term treatment with interferon alfa for myeloproliferative neoplasms
    Kiladjian, Jean-Jacques
    LANCET HAEMATOLOGY, 2017, 4 (04): : E150 - E151
  • [37] Treatment of Polycythemia Vera with hydroxyurea and pipobroman: long term results of a randomized trial
    Kiladjian, J. J.
    Chevret, S.
    Dosquet, C.
    Chomienne, C.
    Rain, J. D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 25 - 26
  • [38] Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera
    Wagner, S. M.
    Melchardt, I
    Greil, R.
    DRUGS OF TODAY, 2020, 56 (03) : 195 - 202
  • [39] HYDROXYUREA (HU) IN THE MANAGEMENT OF POLYCYTHEMIA-VERA (PV) - ANALYSIS OF LONG-TERM LEUKEMOGENIC POTENTIAL
    FRUCHTMAN, SM
    KAPLAN, ME
    PETERSON, P
    MACK, K
    BERK, PD
    WASSERMAN, LR
    CLINICAL RESEARCH, 1992, 40 (02): : A281 - A281
  • [40] Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera
    Kirito, Keita
    Sugimoto, Yuka
    Gotoh, Akihiko
    Takenaka, Katsuto
    Ichii, Michiko
    Inano, Tadaaki
    Shirane, Shuichi
    Ito, Masafumi
    Zagrijtschuk, Oleh
    Qin, Albert
    Kawase, Hiroaki
    Sato, Toshiaki
    Komatsu, Norio
    Shimoda, Kazuya
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (06) : 675 - 683
12345